Antares Pharma Inc Revenue per Employee (ATRS), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Antares Pharma Inc   (NASDAQ: ATRS)
 

Antares Pharma Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Antares Pharma Inc 's Revenue per employee fell on a trailing twelve month basis to $ 537,994, but the productivity of Antares Pharma Inc 's employees remained above the company average.
Within the Healthcare sector Employees of 61 other companies have achieved higher revenue per employee. While Antares Pharma Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 1027. Antares Pharma Inc has 341 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ATRS Revenue per Employee (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter		 (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter
Y / Y Revenue Change -1.25 % 10.42 % 20.47 % 38.89 % 27.22 %
Sales per Employee (TTM) $ 537,994 539,537 526,056 502,044 465,111
ATRS's Total Ranking # 1027 # 0 # 0 # 0 # 0
Seq. Revenue Change -14.72 % 1.12 % 7.14 % 6.88 % -4.65 %

ATRS Company Profile >> Back to ATRS Efficiency Comparisons >> Compare ATRS Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 12
Healthcare Sector # 62
Overall Market # 1027

Revenue per Employee Statistics
High Average Low
$ 539,537 $ 244,034 $ 59,046
(Dec 31 2021)   (March 31, 2014)



Financial Statements
Antares Pharma Inc 's Revenue MRQ $ 42 Millions Visit ATRS's Income Statement
Antares Pharma Inc 's Revenues TTM $ 183 Millions Visit ATRS's aggregate revenue growth
What are ATRS's Sales? Visit ATRS's Sales by Segment




Other Ratios
Antares Pharma Inc 's Income per Employee
Employees in Medical Equipment & Supplies
Medical Equipment & Supplies Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ATRS's Revenue per Employee versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ATRS's Competitors
Revenue per Employee for ATRS's Suppliers
Revenue per Employee for ATRS's Customers

You may also want to know
ATRS's Sales Growth Rates ATRS's Pe Price to earnings ratio ATRS's Receivables Turnover Ratio ATRS's Stock Quote
ATRS's Net Income Growth Rates ATRS's Ps Price to Sales ratio ATRS's Sales per Employee ATRS's Asset Turnover Ratio
ATRS's Net Margin ATRS's Pb Price to Book ratio ATRS's Financial Strength Ratios ATRS's Dividend Payout Ratio
Date modified: 2026-08-29T17:23:07+00:00




Companies with similar Revenue per Employee for 12 months ending Mar 31 2022, within Healthcare Sector Revenue per Employee Revenue 12 months ending Mar 31 2022Number of Employees Mar 31 2022
Clearside Biomedical Inc   934,000.00 $ 29.888  Million 32 
Palvella Therapeutics Inc   923,206.90 $ 26.773  Million 29 
Supernus Pharmaceuticals inc   922,314.42 $ 601.349  Million 652 
Sarepta Therapeutics Inc   917,108.98 $ 765.786  Million 835 
Retractable Technologies Inc  909,834.89 $ 182.877  Million 201 
Healthlynked Corp  902,017.00 $ 9.020  Million 10 
Carlisle Companies Incorporated  894,508.47 $ 5,277.600  Million 5,900 
Biolife Solutions Inc   893,735.48 $ 138.529  Million 155 
Co diagnostics Inc   874,433.72 $ 100.560  Million 115 
Elicio Therapeutics Inc   872,212.12 $ 28.783  Million 33 
Abcellera Biologics Inc   870,183.27 $ 489.043  Million 562 
Privia Health Group Inc   869,831.97 $ 1,066.414  Million 1,226 
Nabriva Therapeutics Plc  859,650.00 $ 34.386  Million 40 
Patterson Companies Inc   855,184.87 $ 6,499.405  Million 7,600 
Catalyst Pharmaceuticals Inc   844,598.90 $ 153.717  Million 182 
Sangamo Therapeutics Inc   793,323.94 $ 112.652  Million 142 
Ngm Biopharmaceuticals Inc   772,550.00 $ 77.255  Million 100 
Myovant Sciences Ltd   772,481.61 $ 230.972  Million 299 
Enanta Pharmaceuticals Inc  763,025.00 $ 91.563  Million 120 
Phenomex Inc   762,859.65 $ 86.966  Million 114 
Cano Health Inc   753,174.44 $ 2,033.571  Million 2,700 
Hologic Inc  712,446.96 $ 5,037.000  Million 7,070 
Reshape Lifesciences Inc  712,166.67 $ 12.819  Million 18 
Fulgent Genetics Inc   709,392.11 $ 953.423  Million 1,344 
Molecular Templates Inc   709,080.65 $ 43.963  Million 62 
Heron Therapeutics Inc   701,445.31 $ 89.785  Million 128 
Merck and Co Inc   700,333.33 $ 52,525.000  Million 75,000 
Pacira Biosciences inc   700,237.64 $ 580.497  Million 829 
Precigen Inc   696,143.75 $ 111.383  Million 160 
Cerus Corporation  687,975.69 $ 198.137  Million 288 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.